Sub-anesthetic ketamine protocols for treatment-resistant depression — guided by experienced clinicians in a calm, monitored setting.
Offered in collaboration with Northshore Health partners, ketamine modulates the brain’s glutamate system and helps restore healthy neural connections that are often damaged in depression and trauma.
Treatment begins with a thorough psychiatric evaluation to confirm candidacy. Ketamine is administered in a carefully monitored setting at a therapeutic dose. Sessions are followed by integration support to help you build on the experience for lasting change.
Adults with treatment-resistant depression and Co-morbid PTSD who have not responded adequately to conventional medications.
Some treatments described here may involve compounded medications or off-label uses of FDA-approved medications. NAD therapy is not FDA-approved to diagnose, treat, cure, or prevent disease, and ketamine is not FDA-approved for psychiatric disorders. Benefits are not guaranteed, results vary, and eligibility requires medical assessment. Read the complete Treatment and FDA Disclaimer.
Schedule a consultation with Dr. Repass and his team for personalized, integrative psychiatric care.